Efficacy of Anlotinib for the Treatment of Angiosarcoma of the Face and Neck: A Case Report
Angiosarcoma of the face and neck is a rare soft tissue sarcoma with a high degree of malignancy. The current treatment methods mainly rely on a combination of surgery and radiotherapy and/or chemotherapy. However, the options for drug treatment are very limited and surgery can be difficult to carry...
Main Authors: | Biyong Ren, Wei Wang, Jing Tan, Bo Yuan, Guilan Chen, Xiaofei Mo, Jieqiong Fan, Bo Yang, Xiaoping Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.596732/full |
Similar Items
-
Efficacy and safety of anlotinib in patients with unresectable or metastatic bone sarcoma: A retrospective multiple institution study
by: Zhiyong Liu, et al.
Published: (2021-11-01) -
Case Report: Two cases of advanced primary cardiac angiosarcoma treated with anlotinib and a retrospective analysis of the literature
by: Pan Yang, et al.
Published: (2024-03-01) -
Postoperative radiotherapy with concomitant temozolomide plus anlotinib for newly diagnosed glioblastoma: Study protocol for a multicenter, double-blind, randomized phase II trial
by: Yuanyuan Chen, et al.
Published: (2022-01-01) -
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient<sup>®</sup> in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
by: Daniel Pink, et al.
Published: (2021-03-01) -
Angiosarcoma of the Head and Neck
by: Brandon Mullins, et al.
Published: (2015-03-01)